SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001193125-14-441359
Filing Date
2014-12-12
Accepted
2014-12-12 17:01:35
Documents
5
Period of Report
2014-10-01
Items
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K/A d834861d8ka.htm 8-K/A 18195
2 EX-23.1 d834861dex231.htm EX-23.1 3490
3 EX-99.1 d834861dex991.htm EX-99.1 210975
4 EX-99.2 d834861dex992.htm EX-99.2 333100
5 EX-99.3 d834861dex993.htm EX-99.3 209600
  Complete submission text file 0001193125-14-441359.txt   776592
Mailing Address 1901 NORTH ROSELLE ROAD, SUITE 700 SCHAUMBURG IL 60195
Business Address 1901 NORTH ROSELLE ROAD, SUITE 700 SCHAUMBURG IL 60195 847-908-1604
Sagent Pharmaceuticals, Inc. (Filer) CIK: 0001369786 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE
Type: 8-K/A | Act: 34 | File No.: 001-35144 | Film No.: 141284283
SIC: 2834 Pharmaceutical Preparations